Showing results (411-420 of 610) with videos related to

Sort By:
Pageof 61
Thrombosis and Haemostasis|April 8, 1988
Monitoring of hemostasis parameters during coronary thrombolysis with recombinant tissue-type plasminogen activatorD C Stump, E J Topol, A B Chen, et al.
Journal of the American College of Cardiology|November 1, 1987
Thrombolytic therapy for unstable angina pectoris: rationale and resultsH K Gold, J A Johns, R C Leinbach, et al.
Thrombosis and Haemostasis|December 22, 1988
Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2M C Alessi, I Juhan-Vague, T Kooistra, et al.
International Journal of Cancer|August 19, 1993
The plasminogen-activation system in ovarian tumorsE Pujade-Lauraine, H Lu, S Mirshahi, et al.
Thrombosis and Haemostasis|September 7, 1992
Synergistic antithrombotic properties of G4120, a RGD-containing synthetic peptide, and argatroban, a synthetic thrombin inhibitor, in a hamster femoral vein platelet-rich thrombosis modelY Imura, J M Stassen, I Vreys, et al.
Journal of Cardiovascular Pharmacology|December 16, 2000
tPA, but not uPA, significantly affects antithrombotic therapy by a glycoprotein IIb/IIIa antagonist, but not by a factor Xa inhibitorM Nishida, H Matsuno, O Kozawa, et al.
Thrombosis and Haemostasis|February 28, 1984
Effect of 24 hours of normoglycaemia on tissue-type plasminogen activator plasma levels in insulin-dependent diabetesI Juhan-Vague, P Vague, C Poisson, et al.
Circulation Research|November 1, 1990
Studies of recombinant plasminogen activator inhibitor-1 in rabbits. Pharmacokinetics and evidence for reactivation of latent plasminogen activator inhibitor-1 in vivoD E Vaughan, P J Declerck, E Van Houtte, et al.
Blood|October 15, 1990
Comparison of intravenous bolus injection or continuous infusion of recombinant single chain urokinase-type plasminogen activator (saruplase) for thrombolysis. A canine model of combined coronary arterial and femoral venous thrombosisH J Rapold, Z M Wu, T Stassen, et al.
The Journal of Clinical Investigation|January 1, 1994
Stimulation with a monoclonal antibody (mAb4E4) of scavenger receptor-mediated uptake of chemically modified low density lipoproteins by THP-1-derived macrophages enhances foam cell generationP Holvoet, G Perez, H Bernar, et al.
Pageof 61